• Lindsay Beck

Over the past several years, high prescription drug prices have caught the attention of past and current administrations, Congress, the media, and the public. Driven by the need to generate value for shareholders and sustain profits, for-profit pharmaceutical companies are major contributors to this problem, imposing excessive launch prices for new drugs and annual price increases for existing ones that often outpace the inflation rate…
Read more...